HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 71802Erstellt: 3. November 2026
Propiomazine Hydrochloride
Propiomazine HCl · Unii-70bo17yr03 · PROPIOMAZINE CHLORIDE) · UGVNGSMLNPWNNA-UHFFFAOYSA-N · Propionylpromazine hydrochloride vetran& · PROPIONYLPROMAZINE HYDROCHLORIDE VETRANA · 1-Propanone, 1-(10-(2-(dimethylamino)propyl)-10H-phenothiazin-2-yl)-, monohydrochloride · Propiomazine D6 hydrochlorideQ: What is Propiomazine D6 hydrochloride Q: What is the CAS Number of Propiomazine D6 hydrochloride Q: What is the storage condition of Propiomazine D6 hydrochloride Q: What are the applications of Propiomazine D6 hydrochloride
https://huagongshe.com/de/chemical/71802
Identifikatoren & physikalische Daten
| CAS No. | 1240-15-9 |
|---|
| Summenformel | C20H25ClN2OS |
|---|
| Durchschnittliche Molmasse | 376,9 g/mol |
|---|
| Monoisotopische Masse | 376,1376123 g/mol |
|---|
| SMILES | CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2.Cl |
|---|
| InChIKey | UGVNGSMLNPWNNA-UHFFFAOYSA-N |
|---|
| PubChem CID | 71802 |
|---|
| ChEMBL | CHEMBL1201068 |
|---|
| DTXSID | DTXSID80872383 |
|---|
Chemische & physikalische Eigenschaften
| Polarare Oberfläche (TPSA) | 48,9 |
|---|
| H-Brücken-Donoren | 1 |
|---|
| H-Brücken-Akzeptoren | 4 |
|---|
| Frei drehbare Bindungen | 5 |
|---|
| Schwere Atome | 25 |
|---|
| Formalladung | 0 |
|---|
| Komplexität | 441 |
|---|
| Human Drugs | FDA approved drugs -> Active ingredient |
|---|
Sicherheit & Vorschriften
| Gesundheitliche Auswirkungen | They cause slurred speech, disorientation and "drunken" behavior. They are physically and psychologically addictive. |
|---|
| Toxizitätsübersicht | Propiomazine is an antagonist at types 1, 2, and 4 dopamine receptors, serotonin (5-HT) receptor types 2A and 2C, muscarinic receptors 1 through 5, alpha(1)-receptors, and histamine H1-receptors. Its main use as a sedative is due to its antihistamine effect. |
|---|
| Signs and Symptoms | Rare, serious side effects include convulsions (seizures)difficult or unusually fast breathingfast or irregular heartbeat or pulsefever (high)high or low blood pressureloss of bladder controlmuscle stiffness (severe)unusual increase in sweatingunusually pale skinand unusual tiredness or weakness. |
|---|
| Carcinogen Classification | No indication of carcinogenicity to humans (not listed by IARC). |
|---|